Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
ABSI

ABSI - Absci Corporation Stock Price, Fair Value and News

$2.39+0.09 (+3.91%)
Market Closed

25/100

ABSI

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

25/100

ABSI

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

ABSI Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

ABSI Price Action

Last 7 days

0.4%

Last 30 days

-8.1%

Last 90 days

-34.3%

Trailing 12 Months

-17.6%

ABSI RSI Chart

ABSI Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

ABSI Valuation

Market Cap

359.4M

Price/Earnings (Trailing)

-3.14

Price/Sales (Trailing)

127.67

EV/EBITDA

-3.42

Price/Free Cashflow

-4.39

ABSI Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

ABSI Fundamentals

ABSI Revenue

Revenue (TTM)

2.8M

Rev. Growth (Yr)

-77.78%

Rev. Growth (Qtr)

-36.26%

ABSI Earnings

Earnings (TTM)

-114.6M

Earnings Growth (Yr)

-4.77%

Earnings Growth (Qtr)

6.09%

ABSI Profitability

EBT Margin

-4062.24%

Return on Equity

-54.49%

Return on Assets

-46.78%

Free Cashflow Yield

-22.8%

ABSI Investor Care

Shares Dilution (1Y)

30.92%

Diluted EPS (TTM)

-0.91

ABSI Alerts

  • 1 major insider buys recently.

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20254.8M4.1M2.8M0
20245.3M3.3M4.2M4.5M
20236.2M8.6M6.9M5.7M
20224.7M4.7M5.5M5.7M
20214.8M4.9M4.9M4.9M
20200004.8M
Get all data in R, Python etc through our Historical Stock Data APIs

About Absci Corporation

ABSI
Absci Corporation operates as a generative AI drug creation company in the United States. Its integrated drug creation platform identifies novel drug targets and creates biotherapeutic candidates. The company was founded in 2011 and is headquartered in Vancouver, Washington.
 CEO
 WEBSITEabsci.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES193

Absci Corporation Frequently Asked Questions

ABSI is the stock ticker symbol of Absci Corporation. Every public company that trades on a stock exchange gets a ticker symbol.

As of Fri Mar 13 2026, market cap of Absci Corporation is 359.39 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Fri Mar 13 2026, ABSI's PE ratio (Price to Earnings) is -3.14 and Price to Sales (PS) ratio is 127.67. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ABSI PE ratio will change depending on the future growth rate expectations of investors.